These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15482785)

  • 21. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC; Ertunc D; Evruke C; Dilek S
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
    Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum anti-müllerian hormone levels in women with secondary amenorrhea.
    La Marca A; Pati M; Orvieto R; Stabile G; Carducci Artenisio A; Volpe A
    Fertil Steril; 2006 May; 85(5):1547-9. PubMed ID: 16616745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The hormonal profile in the polycystic ovary syndrome].
    Donát J; Kohoutek M; Donátová N; Lacinová V
    Cesk Gynekol; 1989 Nov; 54(9):684-8. PubMed ID: 2516481
    [No Abstract]   [Full Text] [Related]  

  • 29. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome.
    Walch K; Grimm C; Nagele F; Huber J; Wölfler M; Vytiska-Binstorfer E; Unfried G; Hefler L
    Acta Obstet Gynecol Scand; 2006; 85(7):869-73. PubMed ID: 16817088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal correlations in the polycystic ovary syndrome.
    Messina M; Milani P; Gentile L
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
    Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
    Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VNTR I/I genotype of insulin gene is associated with the increase of follicle number independent from polycystic ovary syndrome.
    Haller K; Laisk T; Peters M; Talving E; Karits P; Karro H; Uibo R; Salumets A
    Acta Obstet Gynecol Scand; 2007; 86(6):726-32. PubMed ID: 17520407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
    Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
    Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.
    Fleming R; Deshpande N; Traynor I; Yates RW
    Hum Reprod; 2006 Jun; 21(6):1436-41. PubMed ID: 16439501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
    Eldar-Geva T; Margalioth EJ; Gal M; Ben-Chetrit A; Algur N; Zylber-Haran E; Brooks B; Huerta M; Spitz IM
    Hum Reprod; 2005 Jul; 20(7):1814-9. PubMed ID: 15802320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.